Results 91 to 100 of about 740,964 (300)
Aptamer‐based strategies against SARS‐CoV‐2 viruses
The COVID‐19 pandemic, caused by SARS‐CoV‐2, has seriously threatened human life and security in recent years and has had a serious impact on economic development. A range of strategies, including antibodies, small‐molecule agents and vaccines, have been
Yihao Huang +7 more
doaj +1 more source
After the outbreak of the severe acute respiratory syndrome (SARS) in the world in 2003, human coronaviruses (HCoVs) have been reported as pathogens that cause severe symptoms in respiratory tract infections.
Yunlong Wang +15 more
core +1 more source
Expression of SARS-CoV-2 proteins from rVSVNJ-SARS-CoV-2.
To check the expression of SARS-CoV-2 RBD, S1, and SF from rVSVNJ-SARS-CoV-2 infected cells, BHK-21 cells were infected with the virus at an MOI of 6. After six hours incubation at 37°C, cell lysates were prepared and protein expression was determined by
Taewoo Kim (1456888) +30 more
core +1 more source
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics [PDF]
Standl, Fabian +4 more
openaire +2 more sources
Adenosine triphosphate as a modulator of protein interactions and stability
ATP is best known as the cell's energy currency, but it also shapes how proteins fold, interact, aggregate and form biomolecular condensates. This review explains the emerging physical principles behind these effects, including weak binding to charged protein regions, magnesium‐dependent behaviour and concentration‐dependent control of protein ...
Shuyuan Tan, Robin Curtis
wiley +1 more source
Background Studies have shown that Omicron breakthrough infections can occur at higher SARS-CoV-2 antibody levels compared to previous variants. Estimating the magnitude of immunological protection induced from COVID-19 vaccination and previous infection
Alexander Hönning +11 more
doaj +1 more source
Molecular Crowding Modulates SARS‐CoV‐2 Aptamer Affinity
SARS‐CoV‐2 aptamer is a favorable candidate for the recognition and detection of SARS‐CoV‐2, owing to its small size and easy synthesis. However, the issue of compromised binding affinities in real samples and targeting mutant SARS‐CoV‐2 hinder wide ...
Ting Song +6 more
doaj +1 more source
In vaccinees who were infected with SARS-CoV in 2003, we observed greater antibody responses against spike and nucleoprotein of both SARS-CoV-2 and SARS-CoV after a single dosage of inactivated SARS-CoV-2 vaccine.
Huang Liang +18 more
doaj +1 more source
A new study sheds light on how SARS-CoV-2 influences the way natural killer cells can recognize and kill infected cells.
Paola Kučan Brlić, Ilija Brizić
openaire +5 more sources

